Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule

British Journal of Cancer

Volumn 75, Issue 7, 1997, Pages 1035-1043

  Flavell, D J ^a   Boehm, D A ^a   Noss, A ^a   Flavell, S U ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

CD7; Immunotoxin; Saporin; T cell acute lymphoblastic leukaemia

Indexed keywords

ANTIBODY; CD7 ANTIGEN; IMMUNOTOXIN; SAPORIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SCID MOUSE; T CELL LEUKEMIA;

EID: 0030959815     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.177     Document Type: Article

References (27)

1. Adams RA, Pothier L, Flowers A, Lazarus H, Farber S and Foley GE (1970) The question of stemlines in human acute leukemia. Comparison of cells isolated in vitro and in vivo from a patient with acute lymphoblastic leukemia. Exp Cell Res 62: 5-10
2. Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May RM, Carthy M, Richardson J, Ghetie V, Ramilo O, Thorpe, PE, Whr JW and Vitetta ES (1993) A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82: 2624-2633
3. Dorshkind K, Pollack SB, Bosma MJ and Phillips RA (1985) A Natural killer cells are present in mice with severe combined immunodeficiency. J Immunol 134: 3798-3801
4. Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Durkop H, Aversa F, Cornell P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Matelli MF and Stirpe F (1992) Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet 339: 1195-1196
5. Fishwild DM, Aberle S, Bernhard SL and Kung AHC (1992) Efficacy of an anti-CD7-Ricin A chain immunoconjugate in a novel murine model of human T-Cell leukaemia. Cancer Res 52: 3056-3062
6. + human acute T-cell leukaemia cell line. Br J Cancer 64: 274-280
7. Flavell DJ, Cooper S, Morland B, French R and Flavell SU (1992) Effectiveness of combinations of bispecific antibodies for delivering saporin to human acute T-cell lymphoblastic leukaemia cell lines via CD7 and CD38 as cellular target molecules. Br J Cancer 65: 545-551
8. Flavell DJ, Boehm DA, Okayama K, Kohler JA and Flavell SU (1994) Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross linkers. Int J Cancer 58: 407-414
9. Flavell DJ, Boehm D, Emery L, Noss A and Flavell SU (1995a) Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD 19 and anti-CD38 saporin immunotoxins used in combination than with either immunotoxin used alone, Int J Cancer 62: 337-344
10. Flavell DJ, Boehm DA, Emery L, Noss A and Flavell SU (1995b) Comparison of the therapeutic efficacy of anti-CD7 saporin immunotoxins constructed with one or two saporin moieties per immunotoxin molecule in SCID mice with human T-cell leukaemia. 4th International Symposium on Immunotoxins, pp. 135, Myrtle Beach, SC
11. Ghetie V, Swindell E, Uhr JW and Vitetta ES (1993) Purification and properties of immunotoxins containing one vs. two deglycosylated ircin A chains. J Immunol Method 166: 117-122
12. Ghetie V, Engen A, Schnell R and Vitetta ES (1995) The in vivo anti-tumour activity of immunotoxins containing two versus one deglycosylated ricin A chains. Cancer Let 98: 97-101
13. Grossbard ML, Lambert JM,Goldmacher VS, Spector NL, Kinsella J, Eliseo L, Coral F, Taylor JA, Blattler WA, Epstein CL and Nadler LM Anti-B4-blocked ricin: a phase [trial of 7-day continuous infusion in patients with B-cell neoplasms. J Clin Oncol 11: 726-737
14. Jansen B, Vallera DA, Jaszcz WB, Nguyen D and Kersey JH (1992) Successful treatment of human acute T-cell leukaemia in SCID mice using the anti-CD7-deglycosylated ricin A chain immunotoxin DA7. Cancer Res 52: 1314-1321
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680
16. Lambert JM, Senter PD, Yau-Young A, Blatter WA and Goldmacher VS (1983) Purified immunotoxins that are reactive with human lymphoid cells. MAbs conjugated to the RIP's gelomin and PAP. J Biol Chem 260: 12035-12041
17. Marsh JW and Neville DM (1986) Kinetic comparison of ricin immunotoxins: biricin conjugate has potentiated cytotoxicity. Biochemistry 25: 4461-4467
18. May RD, Wheeler HT, Finkelman FD, Uhr JW and Vitetta ES (1991) Intracellular routing rather than cross linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B-cells. Cell Immunol 135: 490-500
19. Morland BJ, Barley J, Boehm D, Flavell SU, Ghaleb N, Kohler JA, Okayama K, Wilkins B and Flavell DJ (1994) Effectiveness of HB2 (anti-CD7)-saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice. Br J Cancer 69: 279-285
20. Myers DE, Yanishevski Y, Masson E, Irvin JD, Evans WE and Uckun FM (1995). Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD19) immunotoxins containing two Pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule. Leukemia Lymphoma 18: 93-102
21. Preijers FWMB (1988) Relationship between internalisation and cytotoxicity of ricin A chain immunotoxins. Br J Haematol 70: 289-294
22. Press OW, Martin PJ, Thorpe PE and Vitetta ES (1988) Ricin A chain containing: immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and maignant T-cells. J Immunol 141: 4410-4417
23. Stirpe F, Gasperi-Campani A, Barbieri L, Falasca A, Abbondanza A and Stevens WA (1983) Ribosome-inactivating proteins from the seeds of Saponaria Officinalis L. (soapwort), of Agrostemma Githago L. (corn cockle) and of Asparagus Officinalis L, (asparagus), and from the latex of Hura Crepitans L. (sandbox tree). J. Biochem, 216: 617-625
24. Thorpe PE, Brown ANF, Jr JAGB, Foxwell BMJ and Stirpe F (1985) An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria Officinalis: potent antitumor effects in vitro and in vivo. J Natl Cancer Inst 75: 151-159
25. Van-Oosterhout YVJM, Van-Den-Herrik-Oudijk IE, Wessels HMC. De-Witte T, Van-de-Winkel JGJ and Preijers FWMB, (1994) Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins. Cancer Res 54: 3527-3532
26. Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D, Ghetie V, Uhr JW and Thorpe PE (1991) Phase 1 immunotoxin trial in patients with B-cell lymphoma. Cancer Res 51. 4052-4058
27. Wargalla UC and Reisfeld RA (1989) Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. Proc Natl Acad Sci USA 86: 5146-5150